Deletion of Nlrp3 in myeloid-derived cells resulted in reduced activation of HSCs and liver fibrosis, whereas deletion of Nlrp3 in HSCs or hepatocytes did not confer protection [128]. This evidence concerns the gene NLRP3 and Hepatic fibrosis.